http://orcid.org/0000-0002-0018-4247
References
- Muroi K, Miyamura K, Okada M, et al. Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. Int J Hematol. 2016;103(2):243–250.
- Ikegame K, Yoshihara S, Taniguchi Y, et al. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation. Exp Hematol. 2011;39(8):880–890.
- Atsuta Y, Morishima Y, Suzuki R, et al. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia. Biol Blood Marrow Transplant. 2012;18(5):780–787.
- Taniguchi Y, Yoshihara S, Hoshida Y, et al. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. Exp Hematol. 2008;36(9):1216–1225.
- Jaiswal SR, Chatterjee S, Chakrabarti S. Paternal bone marrow infusion as salvage therapy for severe GVHD following maternal haploidentical transplantation resulting in biparental chimerism. Int J Hematol. 2013;98(4):504–508.
- Ustun C, Jillella A, Shah R, et al. Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD. Bone Marrow Transplant. 2010;45(11):1658–1660.
- Luznik L, O’Donnell PV, Symons HJ, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008;14(6):641–650.
- Englert C, Ganschow R. Liver transplantation in a child with liver failure due to chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from the same unrelated living donor. Pediatr Transplant. 2012;16(7):E325–E327.